ORCHARD THERAPEUTICS PLC - SPON ADS NEW (ORTX)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / SPON ADS NEW
Total 13F shares
5,809,349
Share change
+5,809,349
Total reported value
$31,194,796
Price per share
$5.37
Number of holders
33
Value change
+$31,194,796
Number of buys
33

Institutional Holders of ORCHARD THERAPEUTICS PLC - SPON ADS NEW (ORTX) as of Q1 2023

As of 31 Mar 2023, ORCHARD THERAPEUTICS PLC - SPON ADS NEW (ORTX) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,809,349 shares. The largest 10 holders included FEDERATED HERMES, INC., Deep Track Capital, LP, CHI Advisors LLC, Temasek Holdings (Private) Ltd, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CITIGROUP INC, Kapitalo Investimentos Ltda, CITADEL ADVISORS LLC, ACADIAN ASSET MANAGEMENT LLC, and PLATINUM INVESTMENT MANAGEMENT LTD. This page lists 33 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.